Back to search

University of British Columbia

Structure, function, and inhibition of type 2 transmembrane serine proteases

Abstract

dc:description

SARS-CoV-2 exploits the activity of surface-expressed human proteases to achieve maturation of its Spike (S) protein and undergo conformational changes that enable virus-host membrane fusion and efficient infection of the airways. Early in the COVID-19 pandemic, Transmembrane Protease, Serine-2 (TMPRSS2) was recognized as a key proteolytic driver of SARS-CoV-2 infection of the human aerodigestive tract, analogous to its role in SARS-CoV-1 cleavage activation, but no TMPRSS2-specific drugs had been developed. This lack of progress was in part due to challenges procuring a recombinant source of the active protease. This thesis describes the first production and purification of fully matured TMPRSS2 protease through protein engineering efforts targeting its zymogen activation motif, leading to its first crystal structures and biochemical interrogations of its interaction with recombinant SARS-CoV-2 S protein substrates. The closely related TMPRSS3 and -4 proteases, which belong to the same Type II Transmembrane Serine Protease (TTSP) family as TMPRSS2, were similarly produced and biochemical investigations revealed that matured TMPRSS3 efficiently cleaves the S protein, potentially explaining SARS-CoV-2 tropisms in cells expressing TMPRSS3 and not TMPRSS2. A platform to identify potent and selective TMPRSS-targeted antivirals was developed using the natural TMPRSS protease inhibitor protein, hepatocyte growth factor activator inhibitor-2 (HAI-2) as a novel scaffold. The protease engineering and inhibition strategies established here may enable future interrogations of TTSP pathobiology in vitro and in vivo and rationally select the most critical proteases for viral pathobiology to disable with potent and selective pharmacological inhibitors, improving our pandemic preparedness against respiratory viruses exploiting this entry pathway.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Interdisciplinary Oncology
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Fraser, Bryan
Contributors dc:contributor
  • Bénard, François
  • Morin, Gregg B.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/88963

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Fraser, Bryan. Structure, function, and inhibition of type 2 transmembrane serine proteases. doctoral thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/88963